Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 231 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANAFRANIL 25MG TABLET Resolved 2024-03-15 2024-03-22 222473
APO-SERTRALINE 25MG CAPSULE Resolved 2024-03-15 2024-05-03 222481
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-04-12 2024-05-31 224977
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-05-10 2024-05-31 227717
APO-HYDRALAZINE 25MG TABLET TABLET Actual shortage 2024-05-24 2024-05-24 228804
APO-ATOMOXETINE 25MG CAPSULE Anticipated shortage 2024-05-30 2024-05-30 229164
APO-NAPRO-NA 275MG TABLET Resolved 2018-05-15 2018-10-05 49499
APO-NAPRO-NA 275MG TABLET Resolved 2022-06-06 2022-08-22 162077
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-11-03 16938
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-05 2021-02-16 133382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-16 2021-09-27 137581
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371

Showing 1661 to 1680 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VORICONAZOLE 200MG TABLET Discontinued 2018-09-08 2018-09-15 60858
IBUPROFEN LIQUID GEL CAPSULES 200MG CAPSULE Discontinued 2019-01-03 2019-01-03 71095
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-01-03 2019-01-03 71112
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-07-22 71439
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-07-12 2019-07-13 89135
APO-PROPRANOLOL 20MG TABLET Discontinued 2017-03-13 2017-03-13 1163
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-ATORVASTATIN 20MG TABLET Discontinued 2018-09-07 2019-02-13 60279
APO-CITALOPRAM 20MG TABLET Discontinued 2018-09-07 2019-02-13 60393
APO-ENALAPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-19 60465
APO-ESCITALOPRAM 20MG TABLET Discontinued 2018-09-07 2018-09-15 60471
APO-FUROSEMIDE 20MG TABLET Discontinued 2018-09-07 2018-09-15 60506
APO-LISINOPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-PAROXETINE 20MG TABLET Discontinued 2018-09-08 2018-09-15 60684
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-12-28 60766
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2019-02-05 60778
APO-SIMVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-11-19 60793
APO-TADALAFIL 20MG TABLET Discontinued 2018-09-10 2019-02-13 61045

Showing 161 to 180 of 356